Stay updated with breaking news from Urologic Association. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
September is Prostate Cancer Awareness Month, and WVU Medicine is encouraging at-risk men to monitor their health with the hospital’s experts and tackle any challenges that arise.
Michael Basin, MD, discusses the rationale for the preclinical investigation of belzutifan resistance in ccRCC cell lines, the next steps for this research, and the potential implications for combining Hsp70 inhibition with a HIF2α inhibitor.
/PRNewswire/ -- Sumitovant Biopharma, Inc. today announced that its portfolio of four wholly-owned subsidiary companies (Urovant, Enzyvant, Altavant and...
/PRNewswire/ -- Sumitovant Biopharma, Inc. today announced that its portfolio of four wholly-owned subsidiary companies (Urovant, Enzyvant, Altavant and...
AUA 2021 events after transurethral resection of intermediate-risk non-muscle invasive bladder cancer (NMIBC), Transurethral resection of bladder tumor (TURBT), patient counseling prior to TURBT, initial TURBT data.